Here is an overview of important key figures for the MEB. This is not a complete reflection of all activities of the MEB.

Medicinal products for human use and marketing authorisations

New applications and authorisations

35 Medicinal products with a new active substance
563 Dutch DCP RMS procedures
1.311 New marketing authorisations (including parallel)
12.462 Variations in existing medicinal product authorisations
14.045 Total number of authorised medicinal products

European representation

124 The Netherlands involved as Scientific Advice coordinator (SAWP)
8 The Netherlands Paediatric Investigation Plan rapporteur (PDCO)
14 The Netherlands rapporteur authorising orphan drug status (COMP)
15 The Netherlands CHMP rapporteur or co-rapporteur
14 The Netherlands involved as PRAC rapporteur

Veterinary medicinal products

Nieuwe aanvragen en inschrijvingen

7 Medicinal products with a new active substance
15 Applications DCP RMS procedures
111 New national marketing authorisations
2.621 Total number of authorised veterinary medicinal products

European representation

8 The Netherlands CVMP rapporteur or co-rapporteur
3 The Netherlands rapporteur or co-rapporteur new Maximum Residue Limits

Botanicals and homeopathica

6 Authorised herbal medicinal products on the basis of traditional use
54 Total number of authorised herbal medicinal products on the basis of traditional use (31 december 2017)
2 Authorised herbal medicinal products on the basis of complete dossier
2.911 Total number of authorised homeopathic medicinal products